Switch to DBT to improve mammo screening performance
Radiologists who switch from 2D mammography to digital breast tomosynthesis...Read more on AuntMinnie.comRelated Reading: Synthesized 2D mammo + DBT works for breast screening Lower recall rate makes DBT better for breast screening More states seek to expand mammography, DBT coverage DBT is comparable to FFDM for detecting benign lesions Digital breast tomosynthesis wins support in Middle East
Publication date: Available online 9 October 2020Source: European Journal of RadiologyAuthor(s): Yan Huang, Qin Xiao, Yiqun Sun, Qin Li, Simin Wang, Yajia Gu
Publication date: Available online 9 October 2020Source: Materials Today: ProceedingsAuthor(s): G. Meenalochini, S. Ramkumar
ConclusionsPatients with ADH on CNB can be stratified into a low oncological cohort who have a 2% risk of being upstaged to carcinoma. In the future, these select patients may be counselled and potentially offered observation as an alternative to surgery.
ConclusionsThis study contains the largest population dataset of ILC evaluated to date. While total breast cancer incidence rates in Ontario are largely unchanged, ILC incidence rates are steadily increasing and there is a trend towards diagnosis of ILC at a later stage. These trends highlight the ongoing diagnostic and treatment challenge ILC presents for patients and clinicians.
Conclusions: This study will provide reliable evidence for intervention for reducing anxiety in women receiving screening mammography. INPLASY registration number: INPLASY202070131.
This study aimed to evaluate the awareness and practice of breast self-examination (BSE) and the awareness of screening and risk factors for breast cancer among patients from a mastology clinic and to associate such findings with sociodemographic factors of that population. A total of 202 randomly selected patients from the outpatient clinic of the Mastology Unit of S ão Paulo School of Medicine were interviewed. A structured questionnaire was used and included questions regarding sociodemographic variables, questions to assess the knowledge and practice of BSE, and knowledge of mammographic screening and risk facto...
Condition: Breast Cancer Intervention: Combination Product: Contrast Enhanced Mammography Sponsors: Karolinska Institutet; Stockholm South General Hospital Not yet recruiting
Not all benign findings on screening mammography are equal. A Spanish team...Read more on AuntMinnie.comRelated Reading: CT scans can predict CVD risk in breast cancer patients Language can be barrier to breast screening Breast screening helps precision medicine succeed Notification laws may not lead to more breast screening Language matters when screening women with dense breasts
CONCLUSIONS: This unique tailored approach to risk assessment will further empower females and clinicians towards a more informed clinical decision process regarding future imaging pathways. It will also inform health policy decisions regarding alternate screening durations and intervals. ADVANCES IN KNOWLEDGE: Breast-iRRISC is a novel tool that provides females, clinicians and health policymakers around the globe with the ability to quantify the lifetime risk of radiation-induced breast cancer from screening mammography on an individual level from a single exposure. PMID: 33031706 [PubMed - as supplied by publisher]